Printer Friendly

COMPANY INFORMATION
Cannasat Therapeutics Inc. 828 Richmond St W Toronto, ON M6J 1C9 Tel: (416) 703-2449 Fax: (416) 703-8752 Contact Name Andrew Williams Industry Pharmaceuticals		Key Executives Anthony J. Giovinazzo, CEO Andrew Williams, CFO Researches the therapeutic benefits of cannabis and develops cannabinoid-based pharmaceutical products.
FP ADVISOR COVERAGE Cannasat Therapeutics Inc. • FP Corporate Surveys • FP Directory of Directors • FP Predecessor & Defunct • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 807,909 Patheon Inc. 765,812 Cangene Corporation 238,751 Dragon Pharmaceutical, Inc. 162,127 Paladin Labs Inc. 82,744 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 5/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX-VEN/CTH $0.10 $0.14 $0.07 n.a. n.a. n.a. n.a. Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 22,230 n.a. $-0.03 June 30/09 -5.0% -24.42% n.a. $8,781
ANNUAL FINANCIALS Periods ended: 12m Dec. 31/08 12m Dec. 31/07 12m Dec. 31/06 $000s $000s $000s Net income (1,992) (2,233) (2,319) Total assets 1,082 2,066 3,374 $ $ $ Earnings per share* (0.03) (0.03) (0.04) % % % Return on equity (193.02) (100.16) (85.76)   * Common

COMPANY NEWS

Results for 'Cannasat Therapeutics Inc.' from past 30 days: No hits. (Links are to articles.)